Clene Inc., (NASDAQ: CLNN)
Published May 7, 2026
Views 10.4K | Likes 366 | Comments 2
At a glance
Views
10,498
Likes
366
Comments
2
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Keynote speakers: Rob Etherington, Preside…
- Published
- May 7, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.